Ignite Creation Date:
2024-05-05 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00205803
Status:
COMPLETED
Last Update Posted:
2012-08-15
First Post:
2005-09-19
Brief Title:
Study Evaluating Pneumococcal Vaccine in Healthy Infants
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Wyeth is now a wholly owned subsidiary of Pfizer
Study Overview
Official Title:
A Phase III 2-stage Randomized Double-Blind Trial of the Safety Tolerability and Immunogenicity of 13-valent Pneumococcal Conjugate Vaccine Serotypes 1 3 4 5 6A 6B 7F 9V 14 18C 19A 19F 23F in Healthy Infants
Status:
COMPLETED
Status Verified Date:
2012-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the safety and immunogenicity of the 13-valent pneumococcal conjugate vaccine 13vPnC in healthy infants This is the first study with this vaccine in infants
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None